CIK 0001512762
- Accelerated filer
- Smaller reporting company
Coherus Oncology, Inc.
Sign in to watch- Ticker
- CHRS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 273615821
- Phone
- +1 650-649-3530
- Business address
- C/O DENNIS M. LANFEAR, 333 TWIN DOLPHIN DR, SUITE 600, REDWOOD CITY, CA, 94065
- Former names
- Coherus BioSciences, Inc., BioGenerics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-01-10 | Richards Christos Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2019-01-11 | Richards Christos Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2018-02-01 | Richards Christos Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2017-05-17 | Richards Christos Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2016-05-24 | Richards Christos Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2015-11-13 | Richards Christos Director | Sale | −7,988 | $27.38 | $219K | 67,848 |
| 2015-11-13 | Richards Christos Director | Sale | −4,012 | $27.93 | $112K | 63,836 |
| 2015-11-12 | Richards Christos Director | Sale | −3,000 | $27.23 | $82K | 75,836 |
| 2015-04-01 | Richards Christos Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2015-04-01 | Richards Christos Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2014-11-12 | Richards Christos Director | Option exercise | +26,505 | $1.67 | $44K | 26,505 |
| 2014-11-12 | Richards Christos Director | Other disposition | −2,956 | 23,549 | ||
| 2014-11-12 | Richards Christos Director | Conversion | +39,991 | 63,540 | ||
| 2014-11-12 | Richards Christos Director | Conversion | +12,672 | 76,212 | ||
| 2014-11-12 | Richards Christos Director | Conversion | +2,624 | 78,836 | ||
| 2014-11-12 | Richards Christos Director | Option exercise · Warrant to Purchase Common Stock | −26,505 | 0 | ||
| 2014-11-12 | Richards Christos Director | Option exercise · Warrant to Purchase Series B Preferred Stock | −429 | 0 | ||
| 2014-11-12 | Richards Christos Director | Option exercise · Series B Preferred Stock | +429 | $0.02 | $7 | 12,673 |
| 2014-11-12 | Richards Christos Director | Other disposition · Series B Preferred Stock | −1 | 12,672 | ||
| 2014-11-12 | Richards Christos Director | Conversion · Series A Preferred Stock | −39,991 | 0 |
Page 1 of 2 · 22 trades